PMV Pharmaceuticals, Inc. announced the appointment of Kirsten Flowers to its Board of Directors. Concurrent with the appointment of Ms. Flowers, Peter Thompson, M.D. will resign from PMV's Board. Ms. Flowers is the Chief Commercial Officer of Kura Oncology, a clinical-stage precision oncology biopharmaceutical company, where she is responsible for building and leading the commercial and medical affairs organization.

Dr. Thompson also resigned as a member of the Company's Compensation Committee and Nominating and Corporate Governance Committee. The term of the Company's Class I directors, including Ms. Flowers', expires on the date of the Company's annual meeting of the stockholders to be held in 2024 or upon the election and qualification of successor directors.